Whole Recombinant Saccharomyces cerevisiae Yeast Expressing Ras Mutations as Treatment for Patients With Solid Tumors Bearing Ras Mutations: Results From a Phase 1 Trial

por Cohn, Allen, Morse, Michael A., O’Neil, Bert, Whiting, Samuel, Coeshott, Claire, Ferraro, John, Bellgrau, Donald, Apelian, David, Rodell, Timothy C.
Publicado 2018

Identification of tumor associated immune responses against brachyury, a transcription factor and driver of EMT, in chordoma patients receiving a yeast-brachyury vaccine (gi-6301)

por Donahue, Renee N, Grenga, Italia, Lepone, Lauren, Gulley, James L, Heery, Christopher R, Madan, Ravi A, Rodell, Timothy C, Schlom, Jeffrey, Farsaci, Benedetto
Publicado 2014

A Phase 2 Randomized Placebo-Controlled Adjuvant Trial of GI-4000, a Recombinant Yeast Expressing Mutated RAS Proteins in Patients with Resected Pancreas Cancer

por Muscarella, Peter, Bekaii-Saab, Tanios, McIntyre, Kristi, Rosemurgy, Alexander, Ross, Sharona B., Richards, Donald A., Fisher, William E., Flynn, Patrick J., Mattson, Alicia, Coeshott, Claire, Roder, Heinrich, Roder, Joanna, Harrell, Frank E., Cohn, Allen, Rodell, Timothy C., Apelian, David
Publicado 2021